Marcio Silva De'Souza
President, CEO & DirectorMr. Marcio Silva De'Souza M.B.A., has been President, Chief Executive Officer and Director of Praxis Precision Medicines, Inc. since April 2020. Mr. De'Souza joined the Praxis Precision Medicines, Inc. in April 2020. He had been an Independent Director of Aeglea BioTherapeutics, Inc since June 18, 2021 until June 2023. He had been an Independent Director of ClearPoint Neuro, Inc. since May 2019 until April 27, 2020. He served as Chief Operating Officer of PTC Therapeutics, Inc. since June 5, 2017 until April 25, 2020. Mr. De'Souza joined PTC in July 2014 as Vice President of Global Marketing and was subsequently Senior Vice President and Head of Global Product Strategy since June 2016, where he was responsible for serving as the chair the integrated program teams as well as leading the global marketing, market access and health economics areas. He serves on the board of directors of Remagine Labs. Prior to joining PTC, he served as an Executive Director of Marketing for NPS Pharmaceuticals, where he led the launch preparations for NATPARA from October 2012 to July 2014. He has worked for Shire Human Genetic Therapies Inc in positions of increasing responsibilities in LATAM, U.S. and globally in several rare disease areas from 2007 to 2012 and Sanofi Genzyme Corporation. Mr. De'Souza holds a Pharmacy and Biochemistry Degree from University of Sao Paulo and has received his MBA from Fundacao Dom Cabral in Brazil.
Positions
- Company NamePraxis Precision Medicines, Inc.Stock CodePRAXPositionPresident, CEO & DirectorColleagues
- DJDean Jonathan MitchellIndependent Chairman of the Board
- TETimothy Edwin KellyCFO & Treasurer
- ANAlex NemiroffGeneral Counsel & Secretary
- SPSteven PetrouCo-Founder and President of Research & Development
- MTMegan T. SniecinskiChief Operating Officer
- WDWilliam Douglas YoungIndependent Director
- GNGregory NordenIndependent Director
- JAJeffrey Allan ChodakewitzIndependent Director
